BACKGROUND: The serotonin transporter gene-linked polymorphic region (5-HTTLPR) has been proposed as a predictor of antidepressant response. Insertion or deletion of a 44-base pair-long region gives rise to short "S" and long "L" forms of the promoter region, the "S" form being associated with reduced serotonin transporter expression. METHODS: A systematic review and meta-analysis was performed to clarify the effect of 5-HTTLPR on antidepressant response and remission rates. Data were obtained from 28 studies with 5408 participants. Three genotype comparisons were tested-SS versus (SL or LL), (SS or SL) versus LL, and SS versus LL. RESULTS: There was no statistically significant effect on antidepressant response. Compared with L carriers, there was an apparent effect of the SS genotype on remission rate (relative risk: .88; 95% confidence interval: .79-.98; p = .02). However, after trim and fill correction for missing data, the effect disappeared (relative risk: .92; 95% confidence interval: .81-1.05; p = .23), indicating that the initial significant effect was likely the result of publication bias. No significant effect on remission rate was seen for SS versus LL and SS/SL versus LL. Substantial unexplained heterogeneity of effect sizes was observed between studies, pointing to additional interacting factors contributing to an association in some cases. CONCLUSIONS: The 5-HTTLPR biallelic short/long polymorphism by itself does not seem to usefully predict antidepressant response. 2010 Society of Biological Psychiatry. Published by Elsevier Inc. All rights reserved.
BACKGROUND: The serotonin transporter gene-linked polymorphic region (5-HTTLPR) has been proposed as a predictor of antidepressant response. Insertion or deletion of a 44-base pair-long region gives rise to short "S" and long "L" forms of the promoter region, the "S" form being associated with reduced serotonin transporter expression. METHODS: A systematic review and meta-analysis was performed to clarify the effect of 5-HTTLPR on antidepressant response and remission rates. Data were obtained from 28 studies with 5408 participants. Three genotype comparisons were tested-SS versus (SL or LL), (SS or SL) versus LL, and SS versus LL. RESULTS: There was no statistically significant effect on antidepressant response. Compared with L carriers, there was an apparent effect of the SS genotype on remission rate (relative risk: .88; 95% confidence interval: .79-.98; p = .02). However, after trim and fill correction for missing data, the effect disappeared (relative risk: .92; 95% confidence interval: .81-1.05; p = .23), indicating that the initial significant effect was likely the result of publication bias. No significant effect on remission rate was seen for SS versus LL and SS/SL versus LL. Substantial unexplained heterogeneity of effect sizes was observed between studies, pointing to additional interacting factors contributing to an association in some cases. CONCLUSIONS: The 5-HTTLPR biallelic short/long polymorphism by itself does not seem to usefully predict antidepressant response. 2010 Society of Biological Psychiatry. Published by Elsevier Inc. All rights reserved.
Authors: Marcus R Munafò; Nelson B Freimer; Whitney Ng; Roel Ophoff; Juha Veijola; Jouko Miettunen; Marjo-Riitta Järvelin; Anja Taanila; Jonathan Flint Journal: Am J Med Genet B Neuropsychiatr Genet Date: 2009-03-05 Impact factor: 3.568
Authors: Patricia Huezo-Diaz; Rudolf Uher; Rebecca Smith; Marcella Rietschel; Neven Henigsberg; Andrej Marusic; Ole Mors; Wolfgang Maier; Joanna Hauser; Daniel Souery; Anna Placentino; Astrid Zobel; Erik Roj Larsen; Piotr M Czerski; Bhanu Gupta; Farzana Hoda; Nader Perroud; Anne Farmer; Ian Craig; Katherine J Aitchison; Peter McGuffin Journal: Br J Psychiatry Date: 2009-07 Impact factor: 9.319
Authors: S J Bull; P Huezo-Diaz; E B Binder; J F Cubells; G Ranjith; C Maddock; C Miyazaki; N Alexander; M Hotopf; A J Cleare; S Norris; E Cassidy; K J Aitchison; A H Miller; C M Pariante Journal: Mol Psychiatry Date: 2008-05-06 Impact factor: 15.992
Authors: M J V Wilkie; G Smith; R K Day; K Matthews; D Smith; D Blackwood; I C Reid; C R Wolf Journal: Pharmacogenomics J Date: 2008-02-05 Impact factor: 3.550
Authors: Susanta K Behura; Pramod Dhakal; Andrew M Kelleher; Ahmed Balboula; Amanda Patterson; Thomas E Spencer Journal: Pharmacol Res Date: 2019-10-07 Impact factor: 7.658
Authors: V M Dotson; F C Hsu; T Y Langaee; C W McDonough; A C King; R A Cohen; A B Newman; S B Kritchevsky; V Myers; T M Manini; M Pahor Journal: J Frailty Aging Date: 2016